Physician profile
William Scott Sheldon
NPI 1124008941
$5,558.68
in general payments reported to CMS, 2019-2025
33 companies · $1,834 in 2025
The $1,834 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $316 · 2021: $695 · 2022: $580 · 2023: $567 · 2024: $332 · 2025: $1,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842 · Travel and Lodging: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.64 |
| Travel and Lodging | $891.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,259.74 | 2021-2025 | Symplicity G3, Onyx Frontier, Euphora |
| Novartis Pharmaceuticals Corporation | $887.87 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $352.68 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $270.82 | 2019-2023 | |
| Amgen INC. | $210.07 | 2019-2023 | Repatha |
| Shockwave Medical, INC | $180.90 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $148.04 | 2021-2025 | Mitraclip |
| Janssen Scientific Affairs, LLC | $124.42 | 2019 | |
| Medtronic Vascular, INC. | $116.12 | 2019 | |
| Penumbra, INC. | $104.35 | 2025 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.28 | 2019-2024 | Lifevest |
| Astellas Pharma US INC | $84.99 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $78.98 | 2019 | |
| Amarin Pharma, INC. | $69.00 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $67.33 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $59.19 | 2019-2022 | |
| Lundbeck LLC | $58.67 | 2019 | |
| Thrombolex, INC. | $56.07 | 2024-2025 | Bashir Endovascular Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.73 | 2019-2023 | Jardiance |
| Abiomed | $55.19 | 2021-2023 | Impella |
| Philips North America LLC | $36.72 | 2020 | |
| Pfizer INC. | $36.58 | 2019-2023 | |
| Terumo Medical Corporation | $28.20 | 2020-2021 | |
| Inari Medical, INC. | $24.00 | 2021 | |
| Impulse Dynamics (USA) INC. | $22.27 | 2023 | Optimizer |
| Angiodynamics, INC. | $20.00 | 2019 | |
| Cordis US Corp. | $15.96 | 2025 | Mynx Control Venous |
| Cardinal Health 200 LLC | $13.20 | 2019 | |
| Ekos Corporation | $11.74 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $11.47 | 2019 | |
| Z-Medica, LLC | $11.10 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sheldon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.